The Effect of Elevated Basal Follicle Stimulating Hormone Levels on Assisted Reproductive Technology Cycle Outcomes

Authors

DOI:

https://doi.org/10.21613/GORM.2019.998

Keywords:

Assisted reproductive technologies, Clinical pregnancy, Follicle-stimulating hormone, Poor ovarian response,

Abstract

OBJECTIVE: Despite the availability of better biomarkers, basal day 3 follicle-stimulating hormone is widely available and often used as the first-line test in ovarian reserve evaluation. The aim of this study was to evaluate the outcomes of cycles with elevated (>12 IU/mL) basal follicle-stimulating hormone values.

STUDY DESIGN: Cycles with basal day 3 follicle-stimulating hormone values >12 IU/mL were divided into four cohorts according to follicle-stimulating hormone levels: group I, follicle-stimulating hormone between 12-15 IU/m, group II between 15-20 IU/mL, group III between 20-25 IU/mL and group IV >25 IU/mL. Both demographic characteristics and controlled ovarian stimulation parameters were retrospectively reviewed.

RESULTS: Total antral follicle count was significantly higher in group I compared to the other three groups (p=0.001). Number of follicles ≥17 mm on human chorionic gonadotropin (hCG) day, number of retrieved oocytes, mature oocytes and fertilized oocytes were significantly higher in group I compared to the other groups (p=0.003, p=0.001, p=0.001, and p=0.001, respectively). No significant difference was found between groups regarding cancellation rates. The rate of embryo transfer per started cycle was significantly higher in group I compared to group III and group IV (p=0.001). Clinical pregnancy rates per embryo transfer were comparable among the groups.

CONCLUSION: Despite the retrieval of lower quantities of oocytes, reasonable pregnancy rates could be achieved if embryo transfer was performed in cycles with follicle-stimulating hormone values over 12 IU/mL.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2020-12-08

How to Cite

1.
Kahyaoglu I, Dogru HY, Aksakal SE, Kaplanoglu I, Dilbaz S, Mollamahmutoglu L. The Effect of Elevated Basal Follicle Stimulating Hormone Levels on Assisted Reproductive Technology Cycle Outcomes. Gynecol Obstet Reprod Med [Internet]. 2020Dec.8 [cited 2021Apr.15];:1-5. Available from: https://www.gorm.com.tr/index.php/GORM/article/view/998

Issue

Section

Reproductive Medicine: Endocrinology and Infertility

Most read articles by the same author(s)

1 2 3 > >>